FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378781586> ?p ?o ?g. }

• W4378781586 endingPage "545" @default.
• W4378781586 startingPage "536" @default.
• W4378781586 abstract "ABSTRACT Background and aims The efficacy of statin therapy is hindered by intolerance to the therapy, leading to discontinuation. Variants in SLCO1B1, which encodes the hepatic transporter OATB1B1, influence statin pharmacokinetics, resulting in altered plasma concentrations of the drug and its metabolites. Current pharmacogenetic guidelines require sequencing of the SLCO1B1 gene, which is more expensive and less accessible than genotyping. In this study, we aimed to develop an easy, clinically implementable functional gene risk score (GRS) of common variants in SLCO1B1 to identify patients at risk of statin intolerance. Methods and results A GRS was developed from four common variants in SLCO1B1. In statin users from Tayside, Scotland, UK, those with a high-risk GRS had increased odds across three phenotypes of statin intolerance [general statin intolerance (GSI): ORGSI 2.42; 95% confidence interval (CI): 1.29–4.31, P = 0.003; statin-related myopathy: ORSRM 2.51; 95% CI: 1.28–4.53, P = 0.004; statin-related suspected rhabdomyolysis: ORSRSR 2.85; 95% CI: 1.03–6.65, P = 0.02]. In contrast, using the Val174Ala genotype alone or the recommended OATP1B1 functional phenotypes produced weaker and less reliable results. A meta-analysis with results from adjudicated cases of statin-induced myopathy in the PREDICTION-ADR Consortium confirmed these findings (ORVal174Ala 1.99; 95% CI: 1.01–3.95, P = 0.048; ORGRS 1.76; 95% CI: 1.16–2.69, P = 0.008). For those requiring high-dose statin therapy, the high-risk GRS was more consistently associated with the time to onset of statin intolerance amongst the three phenotypes compared with Val174Ala (GSI: HRVal174Ala 2.49; 95% CI: 1.09–5.68, P = 0.03; HRGRS 2.44; 95% CI: 1.46–4.08, P &lt; 0.001). Finally, sequence kernel association testing confirmed that rare variants in SLCO1B1 are associated with the risk of intolerance (P = 0.02). Conclusion We provide evidence that a GRS based on four common SLCO1B1 variants provides an easily implemented genetic tool that is more reliable than the current recommended practice in estimating the risk and predicting early-onset statin intolerance." @default.
• W4378781586 created "2023-06-01" @default.
• W4378781586 creator A5019753994 @default.
• W4378781586 creator A5025658524 @default.
• W4378781586 creator A5033219963 @default.
• W4378781586 creator A5046194681 @default.
• W4378781586 creator A5047128701 @default.
• W4378781586 creator A5050049009 @default.
• W4378781586 creator A5060778553 @default.
• W4378781586 creator A5072316288 @default.
• W4378781586 creator A5087774397 @default.
• W4378781586 creator A5088243157 @default.
• W4378781586 date "2023-05-30" @default.
• W4378781586 modified "2023-10-06" @default.
• W4378781586 title "A gene risk score using missense variants in <i>SLCO1B1</i> is associated with earlier onset statin intolerance" @default.
• W4378781586 cites W1604547439 @default.
• W4378781586 cites W1611977445 @default.
• W4378781586 cites W1987464952 @default.
• W4378781586 cites W1998569580 @default.
• W4378781586 cites W2014565106 @default.
• W4378781586 cites W2020427316 @default.
• W4378781586 cites W2027410705 @default.
• W4378781586 cites W2039299577 @default.
• W4378781586 cites W2052144043 @default.
• W4378781586 cites W2063525364 @default.
• W4378781586 cites W2067236087 @default.
• W4378781586 cites W2095010499 @default.
• W4378781586 cites W2139681313 @default.
• W4378781586 cites W2152218609 @default.
• W4378781586 cites W2155634239 @default.
• W4378781586 cites W2156173568 @default.
• W4378781586 cites W2164884234 @default.
• W4378781586 cites W2167980243 @default.
• W4378781586 cites W2168949724 @default.
• W4378781586 cites W2252420292 @default.
• W4378781586 cites W2252904236 @default.
• W4378781586 cites W2584203780 @default.
• W4378781586 cites W2752050463 @default.
• W4378781586 cites W2771232411 @default.
• W4378781586 cites W2905665202 @default.
• W4378781586 cites W2909765747 @default.
• W4378781586 cites W2955142473 @default.
• W4378781586 cites W2970011527 @default.
• W4378781586 cites W3003862064 @default.
• W4378781586 cites W3031020182 @default.
• W4378781586 cites W3133174138 @default.
• W4378781586 cites W3167268391 @default.
• W4378781586 cites W3173022441 @default.
• W4378781586 cites W3203518968 @default.
• W4378781586 cites W3204044187 @default.
• W4378781586 cites W4213127162 @default.
• W4378781586 cites W4249964811 @default.
• W4378781586 cites W4280500521 @default.
• W4378781586 cites W4281658656 @default.
• W4378781586 cites W4284711739 @default.
• W4378781586 cites W4318948364 @default.
• W4378781586 doi "https://doi.org/10.1093/ehjcvp/pvad040" @default.
• W4378781586 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37253618" @default.
• W4378781586 hasPublicationYear "2023" @default.
• W4378781586 type Work @default.
• W4378781586 citedByCount "0" @default.
• W4378781586 crossrefType "journal-article" @default.
• W4378781586 hasAuthorship W4378781586A5019753994 @default.
• W4378781586 hasAuthorship W4378781586A5025658524 @default.
• W4378781586 hasAuthorship W4378781586A5033219963 @default.
• W4378781586 hasAuthorship W4378781586A5046194681 @default.
• W4378781586 hasAuthorship W4378781586A5047128701 @default.
• W4378781586 hasAuthorship W4378781586A5050049009 @default.
• W4378781586 hasAuthorship W4378781586A5060778553 @default.
• W4378781586 hasAuthorship W4378781586A5072316288 @default.
• W4378781586 hasAuthorship W4378781586A5087774397 @default.
• W4378781586 hasAuthorship W4378781586A5088243157 @default.
• W4378781586 hasBestOaLocation W43787815861 @default.
• W4378781586 hasConcept C104317684 @default.
• W4378781586 hasConcept C126322002 @default.
• W4378781586 hasConcept C135763542 @default.
• W4378781586 hasConcept C156957248 @default.
• W4378781586 hasConcept C2776598434 @default.
• W4378781586 hasConcept C2776839432 @default.
• W4378781586 hasConcept C2777300911 @default.
• W4378781586 hasConcept C2779379848 @default.
• W4378781586 hasConcept C54355233 @default.
• W4378781586 hasConcept C55775858 @default.
• W4378781586 hasConcept C71924100 @default.
• W4378781586 hasConcept C86803240 @default.
• W4378781586 hasConcept C98274493 @default.
• W4378781586 hasConceptScore W4378781586C104317684 @default.
• W4378781586 hasConceptScore W4378781586C126322002 @default.
• W4378781586 hasConceptScore W4378781586C135763542 @default.
• W4378781586 hasConceptScore W4378781586C156957248 @default.
• W4378781586 hasConceptScore W4378781586C2776598434 @default.
• W4378781586 hasConceptScore W4378781586C2776839432 @default.
• W4378781586 hasConceptScore W4378781586C2777300911 @default.
• W4378781586 hasConceptScore W4378781586C2779379848 @default.
• W4378781586 hasConceptScore W4378781586C54355233 @default.
• W4378781586 hasConceptScore W4378781586C55775858 @default.
• W4378781586 hasConceptScore W4378781586C71924100 @default.
• W4378781586 hasConceptScore W4378781586C86803240 @default.

• next